When food intake drops further on GLP1s, total nutrient intake can fall below requirements even if weight loss is on track. In a large US database study of 461,382 adults on GLP1 medications, 12.7% were newly diagnosed with a nutritional deficiency by 6 months and 22% by 12 months, with vitamin D deficiency most common
However, some individuals may lose up to 30% body fat loss when higher doses of tirzepatide are combined with a healthy lifestyle

HbA1c Once-weekly subcutaneous administration of tirzepatide dose-dependently reduced HbA1c levels across all studies using the combination of GLP-1 and GIP.2, 3, 4, 5, 6 The results of the SURPASS-2 study showed that individuals who had established T2DM and were treated with tirzepatide at doses ranging from 5 to 15 mg for a duration of 40 weeks experienced a reduction in HbA1c levels ranging from 2.09% to 2.46%.3 This reduction was higher than that observed in individuals treated with semaglutide (1 mg), who experienced a 1.86% reduction in HbA1c levels.3 Similarly, in the SURPASS-3 study, individuals who received tirzepatide at doses ranging from 5 to 15 mg for 52 weeks experienced a reduction in HbA1c levels ranging from 1.93% to 2.37%, which was higher than that observed in individuals treated with insulin degludec, who experienced a decrease of 1.34%.4 In Japanese individuals with T2DM, after 52 weeks of treatment, tirzepatide at doses ranging from 5 to 15 mg reduced HbA1c levels by 2.4%3.02%.27 Additionally, in this population, tirzepatide was more effective in controlling blood glucose levels than dulaglutide administered once weekly at a dose of 0.75 mg.27 Collectively, tirzepatide elicited a much stronger HbA1c-lowering effect in all the SURPASS programs compared with placebo or active comparators, including GLP-1 RA and basal insulin.2, 3, 4, 5, 6, 27 Table 1 summarizes the main findings of the SURPASS programs and details the HbA1c lowering efficacy of tirzepatide

Examples of impurities : [1-31]-Tirzepatide, Tirzepatide Acid, Glu(19)-Tirzepatide, Glu(24)-Tirzepatide, [-Asp-9, -Asp-15]-Tirzepatide, Endo-Pro(38)-Tirzepatide, [Des-AEEA4]-Tirzepatide, [Endo-AEEA4]-Tirzepatide, [D-Ser8]-Tirzepatide, [D-Ser32]-Tirzepatide, [Kyn25]-Tirzepatide, Trp(O)-Tirzepatide, Cycli-Tyr-Tirepatide Daicel Pharma Standards Contribution Daicel Pharma Standards provides a comprehensive portfolio of fully characterized GLP-1 peptide drug impurity standards, including degradation-related impurities for Liraglutide, Semaglutide, and Tirzepatide
This level of care is what sets Skin Artisans apart